255 related articles for article (PubMed ID: 36700645)
1. Catalytically Active Metal-Organic Frameworks Elicit Robust Immune Response to Combination Chemodynamic and Checkpoint Blockade Immunotherapy.
Wang X; Luo J; Wang J; Cao J; Hong Y; Wen Q; Zeng Y; Shi Z; Ma G; Zhang T; Huang P
ACS Appl Mater Interfaces; 2023 Feb; 15(5):6442-6455. PubMed ID: 36700645
[TBL] [Abstract][Full Text] [Related]
2. Cu-MOF chemodynamic nanoplatform via modulating glutathione and H
Tian H; Zhang M; Jin G; Jiang Y; Luan Y
J Colloid Interface Sci; 2021 Apr; 587():358-366. PubMed ID: 33360905
[TBL] [Abstract][Full Text] [Related]
3. Glutathione/pH-responsive copper-based nanoplatform for amplified chemodynamic therapy through synergistic cycling regeneration of reactive oxygen species and dual glutathione depletion.
Jia S; Ke S; Tu L; Chen S; Luo B; Xiong Y; Li Y; Wang P; Ye S
J Colloid Interface Sci; 2023 Dec; 652(Pt A):329-340. PubMed ID: 37597414
[TBL] [Abstract][Full Text] [Related]
4. A metal-organic framework (MOF) built on surface-modified Cu nanoparticles eliminates tumors via multiple cascading synergistic therapeutic effects.
An G; Zheng H; Guo L; Huang J; Yang C; Bai Z; Wang N; Yang W; Zhu Y
J Colloid Interface Sci; 2024 May; 662():298-312. PubMed ID: 38354557
[TBL] [Abstract][Full Text] [Related]
5. Protein-Delivering Nanocomplexes with Fenton Reaction-Triggered Cargo Release to Boost Cancer Immunotherapy.
Li X; Zhou Q; Japir AAMM; Dutta D; Lu N; Ge Z
ACS Nano; 2022 Sep; 16(9):14982-14999. PubMed ID: 36017992
[TBL] [Abstract][Full Text] [Related]
6. A Lactate-Depleting metal organic framework-based nanocatalyst reinforces intratumoral T cell response to boost anti-PD1 immunotherapy.
Zhou J; Hu Y; Cao Y; Ding S; Zeng L; Zhang Y; Cao M; Duan G; Zhang X; Bian XW; Tian G
J Colloid Interface Sci; 2024 Apr; 660():869-884. PubMed ID: 38277843
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in nanoscale metal-organic frameworks for cancer chemodynamic therapy.
Ji M; Liu H; Gou J; Yin T; He H; Zhang Y; Tang X
Nanoscale; 2023 May; 15(20):8948-8971. PubMed ID: 37129051
[TBL] [Abstract][Full Text] [Related]
8. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
Ni K; Luo T; Nash GT; Lin W
Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-Adapted Sono-chemodynamic Treatment of Orthotopic Pancreatic Carcinoma Using Copper Metal-Organic Frameworks Loaded with an Ultrasound-Induced Free Radical Initiator.
Sun Y; Cao J; Wang X; Zhang C; Luo J; Zeng Y; Zhang C; Li Q; Zhang Y; Xu W; Zhang T; Huang P
ACS Appl Mater Interfaces; 2021 Aug; 13(32):38114-38126. PubMed ID: 34357760
[TBL] [Abstract][Full Text] [Related]
10. Sulfonated vitamin K3 mediated bimetallic metal-organic framework for multistage augmented cancer therapy.
Ke Q; Jing P; Wan Y; Xia T; Zhang L; Cao X; Jiang K
J Colloid Interface Sci; 2024 Jan; 654(Pt A):224-234. PubMed ID: 37839239
[TBL] [Abstract][Full Text] [Related]
11. A self-amplified nanocatalytic system for achieving "1 + 1 + 1 > 3" chemodynamic therapy on triple negative breast cancer.
Zhou L; Chen J; Sun Y; Chai K; Zhu Z; Wang C; Chen M; Han W; Hu X; Li R; Yao T; Li H; Dong C; Shi S
J Nanobiotechnology; 2021 Sep; 19(1):261. PubMed ID: 34481495
[TBL] [Abstract][Full Text] [Related]
12. Dual-Functional Nanoplatform Based on Bimetallic Metal-Organic Frameworks for Synergistic Starvation and Chemodynamic Therapy.
Xiao Y; Lai F; Xu M; Zheng D; Hu Y; Sun M; Lv N
ACS Biomater Sci Eng; 2023 Apr; 9(4):1991-2000. PubMed ID: 36989499
[TBL] [Abstract][Full Text] [Related]
13. Cyclic amplification of intracellular ROS boosts enzymatic prodrug activation for enhanced chemo-immunotherapy.
Liu Y; Jiang M; Zhao Z; Wang N; Wang K; Yuan Y
Acta Biomater; 2023 Aug; 166():567-580. PubMed ID: 37207741
[TBL] [Abstract][Full Text] [Related]
14. Transformable prodrug nanoplatform
Yang W; Yi J; Zhu R; Guo Y; Zhang K; Cao Y; Li X; Zhang J; Zhang Z; Li Y; Chen X
Theranostics; 2023; 13(6):1906-1920. PubMed ID: 37064869
[No Abstract] [Full Text] [Related]
15. Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy.
Xie L; Wang G; Sang W; Li J; Zhang Z; Li W; Yan J; Zhao Q; Dai Y
Biomaterials; 2021 Feb; 269():120638. PubMed ID: 33421711
[TBL] [Abstract][Full Text] [Related]
16. Metal-Organic Framework-Based Nanoagents for Effective Tumor Therapy by Dual Dynamics-Amplified Oxidative Stress.
Chen J; Wang Y; Niu H; Wang Y; Wu A; Shu C; Zhu Y; Bian Y; Lin K
ACS Appl Mater Interfaces; 2021 Sep; 13(38):45201-45213. PubMed ID: 34525803
[TBL] [Abstract][Full Text] [Related]
17. A carbon dot-doped Cu-MOF-based smart nanoplatform for enhanced immune checkpoint blockade therapy and synergistic multimodal cancer therapy.
Su Z; Xu H; Zhang Y; Zhang H; Zhang H; Bao Y; Wu X; Yan R; Tan G; Wang Z; Jin Y
J Mater Chem B; 2023 May; 11(19):4211-4226. PubMed ID: 37114499
[TBL] [Abstract][Full Text] [Related]
18. Covalent Organic Framework-Based Nanocomposite for Synergetic Photo-, Chemodynamic-, and Immunotherapies.
Liu S; Zhou Y; Hu C; Cai L; Pang M
ACS Appl Mater Interfaces; 2020 Sep; 12(39):43456-43465. PubMed ID: 32880166
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu
Zhou Z; Gao Z; Chen W; Wang X; Chen Z; Zheng Z; Chen Q; Tan M; Liu D; Zhang Y; Hou Z
Acta Biomater; 2022 Oct; 151():600-612. PubMed ID: 35953045
[TBL] [Abstract][Full Text] [Related]
20. Mn
Li W; Li R; Ye Q; Zou Y; Lu X; Zhang W; Chen J; Zhao Y
Adv Healthc Mater; 2023 Jun; 12(15):e2202280. PubMed ID: 36753620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
